Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Vývoj problémového užívání opioidů na území České republiky: literární přehled
[Development of problems opioid use on the territory of the Czech Republic: a literature review]

Malinovská Jana, Mravčík V.

. 2017 ; 17 (4) : 282-291.

Language Czech Country Czech Republic

Document type Review

Digital library NLK
Source

E-resources Online

SUMMARY: This article presents a literature review of published and grey literature focused on problem opioid use (POU) on the territory of the CR. The development of POU in the CR can be divided into 4 periods, all characterised by injecting opioid use. The period before 1989 was typified by misuse of opioid analgesics and home-made drugs (braun). The first half of the 1990s was significant for the emergence of the so-called heroin epidemic as illegally transported heroin gained a dominant position on the drug scene. Subutex has been available in the CR since 2000 and its leakage on the illicit drug market has been observed since 2002, characterised by the sale and purchase of small surplus quantities of buprenorphine obtained through doctor shopping. The increase in the illicit problem use of buprenorphine is associated with consequent decrease in heroin use and the heroin market. Buprenorphine is currently the most used opioid among POU in the CR. There has been reemerging increase in the use of opioid analgesics for the past 5 years, esp. in the regions with typically high prevalence of POU. The misuse of both buprenorphine and opioid analgesics is related to the limited affordability and local availability of opiate substitution treatment (OST) in the CR. The prevalence of POU in the CR was estimated at 12,700 users in 2015, i.e. 27.1% of all the 46,900 estimated problem drug users. The development of POU went through periods of misuse of opioid analgesics and later of substitution products characterised by a great amount of self-supplying and an unorganised market, in comparison to the highly organised commercial market with heroin. POU in the CR is characteristic of a high level of injecting which represents a considerable public health issue. It is therefore necessary to scale-up specific therapeutic and harm reduction interventions for POU, esp. OST.

Development of problems opioid use on the territory of the Czech Republic: a literature review

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc18000621
003      
CZ-PrNML
005      
20181206110027.0
007      
ta
008      
180114s2017 xr f 000 0|cze||
009      
AR
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Malinovská, Jana $7 xx0253336 $u Department of Addictology, First Faculty of Medicine, Charles University, and General University Hospital, Prague
245    10
$a Vývoj problémového užívání opioidů na území České republiky: literární přehled / $c Malinovská Jana, Mravčík V.
246    31
$a Development of problems opioid use on the territory of the Czech Republic: a literature review
504    __
$a Literatura
520    9_
$a SUMMARY: This article presents a literature review of published and grey literature focused on problem opioid use (POU) on the territory of the CR. The development of POU in the CR can be divided into 4 periods, all characterised by injecting opioid use. The period before 1989 was typified by misuse of opioid analgesics and home-made drugs (braun). The first half of the 1990s was significant for the emergence of the so-called heroin epidemic as illegally transported heroin gained a dominant position on the drug scene. Subutex has been available in the CR since 2000 and its leakage on the illicit drug market has been observed since 2002, characterised by the sale and purchase of small surplus quantities of buprenorphine obtained through doctor shopping. The increase in the illicit problem use of buprenorphine is associated with consequent decrease in heroin use and the heroin market. Buprenorphine is currently the most used opioid among POU in the CR. There has been reemerging increase in the use of opioid analgesics for the past 5 years, esp. in the regions with typically high prevalence of POU. The misuse of both buprenorphine and opioid analgesics is related to the limited affordability and local availability of opiate substitution treatment (OST) in the CR. The prevalence of POU in the CR was estimated at 12,700 users in 2015, i.e. 27.1% of all the 46,900 estimated problem drug users. The development of POU went through periods of misuse of opioid analgesics and later of substitution products characterised by a great amount of self-supplying and an unorganised market, in comparison to the highly organised commercial market with heroin. POU in the CR is characteristic of a high level of injecting which represents a considerable public health issue. It is therefore necessary to scale-up specific therapeutic and harm reduction interventions for POU, esp. OST.
650    _2
$a lidé $7 D006801
650    _2
$a nelegální distribuce léčiv na předpis $7 D064226
650    _2
$a obchodování s drogami $7 D064423
650    _2
$a methamfetamin $7 D008694
650    _2
$a heroin $7 D003932
650    _2
$a buprenorfin $7 D002047
650    12
$a opioidní analgetika $x aplikace a dávkování $x ekonomika $7 D000701
650    _2
$a opiátová substituční terapie $x ekonomika $x využití $7 D058850
650    _2
$a intravenózní abúzus drog $7 D015819
650    12
$a poruchy spojené s užíváním opiátů $x dějiny $x epidemiologie $x komplikace $7 D009293
651    _2
$a Česká republika $7 D018153
655    _2
$a přehledy $7 D016454
700    1_
$u Department of Addictology, First Faculty of Medicine, Charles University, and General University Hospital, Prague; National Monitoring Centre for Drug and Addiction, Office of the Government, Czech Republic; National Institute of Mental Health, Czech Republic
773    0_
$t Adiktologie $x 1213-3841 $g Roč. 17, č. 4 (2017), s. 282-291 $w MED00012365
856    41
$u https://www.addictology.cz/wp-content/uploads/2018/10/kapitoly_6-2.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 4153 $c 611 $y 4 $z 0
990    __
$a 20180114071816 $b ABA008
991    __
$a 20181206110141 $b ABA008
999    __
$a ok $b bmc $g 1267728 $s 997276
BAS    __
$a 3
BMC    __
$a 2017 $b 17 $c 4 $d 282-291 $i 1213-3841 $m Adiktologie $x MED00012365
LZP    __
$c NLK185 $d 20180226 $a NLK 2018-03/vt

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...